MetLife Investment Management’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$259K Buy
4,782
+223
+5% +$14.6K ﹤0.01% 2088
2025
Q4
$280K Hold
4,559
﹤0.01% 2105
2025
Q3
$333K Sell
4,559
-348
-7% -$27.4K ﹤0.01% 2023
2025
Q2
$365K Hold
4,907
﹤0.01% 1837
2025
Q1
$368K Sell
4,907
-84
-2% -$7.8K ﹤0.01% 1870
2024
Q4
$510K Hold
4,991
﹤0.01% 1787
2024
Q3
$526K Hold
4,991
﹤0.01% 1755
2024
Q2
$465K Buy
4,991
+432
+9% +$45.8K ﹤0.01% 1755
2024
Q1
$594K Hold
4,559
﹤0.01% 1583
2023
Q4
$517K Hold
4,559
﹤0.01% 1665
2023
Q3
$374K Hold
4,559
﹤0.01% 1805
2023
Q2
$428K Hold
4,559
﹤0.01% 1802
2023
Q1
$310K Buy
4,559
+152
+3% +$12.3K ﹤0.01% 1936
2022
Q4
$313K Sell
4,407
-565
-11% -$38.5K ﹤0.01% 1952
2022
Q3
$309K Sell
4,972
-89
-2% -$6.41K ﹤0.01% 1998
2022
Q2
$338K Hold
5,061
﹤0.01% 1938
2022
Q1
$364K Buy
5,061
+1,588
+46% +$130K ﹤0.01% 1975
2021
Q4
$333K Hold
3,473
﹤0.01% 1745
2021
Q3
$170K Hold
3,473
﹤0.01% 2192
2021
Q2
$175K Buy
+3,473
New +$171K ﹤0.01% 2241
2019
Q4
Sell
-4,247
Closed -$137K 2305
2019
Q3
$137K Buy
+4,247
New +$107K ﹤0.01% 2157
2018
Q4
Sell
-4,469
Closed -$141K 2572
2018
Q3
$141K Hold
4,469
﹤0.01% 2279
2018
Q2
$168K Buy
+4,469
New +$175K ﹤0.01% 1998

Other funds holding BXC

MetLife Investment Management's BXC Position: Q1 2026 in Review

MetLife Investment Management increased its BlueLinx (BXC) stake by 4.9% in Q1 2026, buying an estimated $14.6K and bringing the position to 4,782 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #2088.

MetLife Investment Management first reported a position in BXC in Q2 2018 and has held it in 23 quarters since. The position peaked at $594K in Q1 2024. 145 funds tracked by Wall St. Rank hold BXC as of Q1 2026.

  • MetLife Investment Management held 4,782 shares of BlueLinx worth $259K as of Q1 2026.
  • MetLife Investment Management bought 223 BlueLinx shares in Q1 2026, an estimated $14.6K.
  • BlueLinx made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2088 holding.
  • MetLife Investment Management first reported a position in BlueLinx in Q2 2018 and has held it in 23 quarters since.
  • MetLife Investment Management's BlueLinx position peaked at $594K in Q1 2024.
  • 145 funds tracked by Wall St. Rank held BlueLinx as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.